MN-ENTRUST
Entrust , a leading provider of trusted identities, payments and data protection, today announced the Sigma® Instant Desktop Issuance solution, an innovative direct-to-card solution for instant physical and mobile ID issuance. Designed for both cloud and on-premise deployment, the Sigma solution sets the standard for simple, secure and smart instant ID solutions across enterprise, healthcare, government, higher education and financial institutions.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201019005238/en/
Today’s enterprises face a myriad of security challenges: From transitioning to digital operations during the pandemic, to managing the global rise in cyber-attacks, they must maintain a safe and secure flow of data − including the data stored on physical credentials. Within these organizations, Identity and Access Management professionals require a printing solution that is not only easy to integrate into their operations, but one that evolves to meet the growing needs of their company while assuring the highest level of data security. Sigma systems deliver a seamless user experience across the issuance process for desktop and mobile printing needs. It eliminates the frustrations of printer set-up with a modular design and an out-of-the-box implementation that takes less than 30 minutes for users to begin issuing identities.
Equipped with cloud-based APIs, Sigma systems bring issuance to the cloud without additional hardware — enabling instant printing for both physical IDs, badges and payment cards. Sigma systems are trusted IoT devices that help ensure organizations and their data are safe with an intelligent network and building connectivity for ultimate enterprise protection. With capabilities like tactile impressions, holographic and luster panel printing, Sigma printers make it highly difficult for counterfeiters to alter or recreate cards. Additionally, features like an inline magnetic stripe and smart card encoding secure your cards during the card printing process.
“With our Sigma platform, we’re proud to deliver a best-in-class desktop credential issuance solution that’s designed to work completely and securely within a cloud environment, allowing financial, enterprise, government, higher education and healthcare organizations to meet high-volume issuance demands without sacrificing security or ease of use. The Sigma system is ready to meet the issuance needs of today, and equally important, will evolve to meet tomorrow’s security and technology challenges with unlimited printing applications,” said Tony Ball, Senior Vice President and General Manager of Instant Issuance at Entrust. “Entrust has been a pioneer in direct-to-card identity issuance technology for decades, and our Sigma system takes it to a whole new level.”
Sigma systems offer the most advanced security architecture that keeps data protected at each step of the issuance process:
- Encrypted connections: The connection and data sent between software and the printer are secure and encrypted. Sigma printers do not store customer data after successful printing is complete.
- Secure boot: This feature prevents Sigma systems from booting up malware or other compromises are detected.
- Trusted platform module (TPM): Organizations can store and manage user certificates and keys in the printer, allowing the printer to become a trusted internet of things (IoT) endpoint.
As large segments of the workforce continue operating remotely, Sigma systems are poised to meet the demands of a hybrid workforce with its physical and digital issuance platform. The Sigma system’s “Printer Dashboard” is available on mobile devices, allowing organizations to manage the printer from anywhere, without being tied to a desktop. Sigma systems also enable companies to pivot and move to a contactless ID Issuance experience, from online photo submission to validating the photo, printing the card, and ultimately delivering the card to the employee. Furthermore, the on-premises instant ID solution features a mobile enrollment functionality for added flexibility to issue IDs at various locations within a facility. Sigma systems use intelligent instant ID technology to streamline printing and eliminate manual workflows — bringing simplicity, security and flexibility to the issuance process.
“Whether your requirements demand an integrated, secure on-premises solution or a system that can grow with a distributed workforce via a secure cloud-hosted Identity Management offering, the Entrust Sigma solutions can meet your needs,” said Joe Franco, Director of Sales at Capture Technologies, an Entrust channel partner. “They are browser based and mobile ready and able to be deployed without the need for a heavy client to be installed. The certificate based integrated security features should put to rest any concerns about using the cloud for identity issuance or your printing solution being vulnerable to network attack.”
For more information about Sigma visit: https://www.entrust.com/c/meet-sigma .
About Entrust
Entrust keeps the world moving safely by enabling trusted identities, payments and data protection. Today more than ever, people demand seamless, secure experiences, whether they’re crossing borders, making a purchase, accessing e-government services or logging into corporate networks. Entrust offers an unmatched breadth of digital security and credential issuance solutions at the very heart of all these interactions. With more than 2,500 colleagues, a network of global partners, and customers in over 150 countries, it’s no wonder the world’s most entrusted organizations trust us. To learn more, visit www.entrust.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20201019005238/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
